Laboratory Tests |
Blood Tests; Urine Tests |
Clinical Trial: Comparison of Screening Tests in Detecting Cervical Neoplasia
This study is no longer recruiting patients.
Purpose
RATIONALE: Screening tests may help doctors detect abnormal cells in the cervix early and plan effective treatment.
PURPOSE: Screening trial to compare different types of screening tests used to detect cervical neoplasia.
| Condition | Treatment or Intervention |
|---|---|
| Cervical Cancer | Procedure: annual screening Procedure: colposcopic biopsy Procedure: comparison of screening methods Procedure: cytologic sampling Procedure: diagnostic test Procedure: screening intervention Procedure: vaginal smears |
MedlinePlus related topics: Cervical Cancer
Study Type: Observational
Study Design: Screening
Official Title: Study of Primary Screening Strategies For the Detection of Cervical Neoplasia
OBJECTIVES:
- Compare the sensitivity and specificity of primary screening strategies for the detection of cervical intraepithelial or invasive neoplasia.
- Compare the positive and negative predictive values of these strategies.
OUTLINE: This is a multicenter study. Patients are stratified according to the reason for the visit (general gynecological screening vs colposcopy referral).
- Stratum 1 (general gynecological screening): Patients undergo Pap smear, visual inspection aided by acetic acid (VIA), a colposcopy, and finally a visual inspection aided by toluidine blue (VIT) followed by an acetic acid wash. A biopsy may be performed at this initial visit. Within 2-3 weeks, patients are notified of results.
- Stratum 2 (colposcopy referral): Patients undergo Pap smear, VIA, colposcopy, VIT, and possible biopsy as in stratum 1. During the same visit, patients receive histologic evaluation and treatment with See-and-Treat loop electrosurgical excision procedure and/or endocervical curettage.
PROJECTED ACCRUAL: A total of 600-1,000 patients (300-500 per stratum) will be accrued for this study.
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
DISEASE CHARACTERISTICS:
- History of cervical neoplasia
- Presenting for a well-woman visit, annual Pap smear, or family planning
- Other gynecological or non-gynecological complaints allowed OR
- Referred for colposcopy secondary to an abnormal Pap smear
- Planned screening for cervical cancer
PATIENT CHARACTERISTICS: Age:
- Over 18
Performance status:
- Not specified
Life expectancy:
- Not specified
Hematopoietic:
- No bleeding diathesis
Hepatic:
- Not specified
Renal:
- Not specified
Other:
- Not pregnant
PRIOR CONCURRENT THERAPY: Biologic therapy:
- Not specified
Chemotherapy:
- Not specified
Endocrine therapy:
- Not specified
Radiotherapy:
- Not specified
Surgery:
- Prior laser surgery, cryotherapy, or conization or loop electrosurgical excision procedure for cervical neoplasia allowed
- No prior hysterectomy
Other:
- No concurrent anticoagulants
Location Information
California
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, 90095-1781, United States
Christine Holschneider, MD, Study Chair, Jonsson Comprehensive Cancer Center
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
Record last reviewed: October 2003
Last Updated: October 13, 2004
Record first received: June 6, 2002
ClinicalTrials.gov Identifier: NCT00039312
Health Authority: Unspecified
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


